Patents

UNPARALLEL ADVANTAGE SUPPORTED BY OUR GROUNDBREAKING PATENTS

INFINICLONE-IMMUNOVEST Technologies

Our biotech company's portfolio of patents encompasses groundbreaking innovations that grant us an unparalleled advantage in the industry. These cutting-edge technologies and methodologies revolutionize the field of stem-cells, immunology. Our patents provide us with a unique competitive edge, positioning us as pioneers in the forefront of biotechnological advancements.

Patented Microcarriers (US 8828720B2)

To form microcarriers-stem cell complex in 3D culture

Allow upscaling while maintaining multipotency

Improved Capacity

Patented Pluripotency Markers (US 8710190B2)

Ability to differentiate between undifferentiated & differentiated stem cells

Allow for depletion of undifferentiated stem cells

Improved Purity

Patented Additives (US 9150829B2)

Ability to maintain cell stability in long-term culture

Allow cell expansion & differentiation without reseeding cells

Improved Stability

Patented Safety Markers (US 2011/0171183 A1)

Antibody markers for treating culture to remove undifferentiated ESC & cancer stem cells

Improved Safety